In this study, each dose group of YQHYJD downregulated the expressions of PI3K-AKT pathway downstream protein AKT1 and MAPK pathway activating protein KRAS/NRAS/HRAS to different extents, which played a role in the intervention of ARDS. The gene discussed is HRAS; the disease is acute respiratory distress syndrome.